Which medications in the drug class Alkylating Agents are used in the treatment of Burkitt Lymphoma and Burkitt-like Lymphoma?

Updated: Dec 20, 2019
  • Author: Ali H Kanbar, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Alkylating Agents

Alkylating agents inhibit cell growth and proliferation.

Cyclophosphamide (Cytoxan)

Cyclophosphamide is cell cycle nonspecific and involves hepatic metabolism. This agent is chemically related to nitrogen mustards. As an alkylating agent, the mechanism of action of the active metabolites may involve cross-linking of DNA, which may interfere with growth of normal and rapidly proliferating malignant cells.

Ifosfamide (Ifex)

Ifosfamide is chemically related to nitrogen mustards and is a synthetic analogue of cyclophosphamide. This agent requires metabolic activation in the liver. The alkylated metabolites of ifosfamide have been shown to react with cellular DNA. This agent inhibits DNA and protein synthesis and, thus, cell proliferation by causing DNA cross-linking and denaturation of double helix.

Vincristine (Oncovin)

The mechanism of action of vincristine is uncertain. This agent is cell cycle specific at the M and S phases and inhibits microtubule assembly at metaphase, resulting in cell division arrest. Approximately 80% of vincristine is excreted by the liver. This agent may cause a decrease in reticuloendothelial cell function or an increase in platelet production.

Methotrexate (Folex PFS)

Methotrexate is cell cycle S-phase specific. This agent inhibits enzyme dihydrofolate reductase (DHFR), resulting in decreased conversion of folic acid to tetrahydrofolate, which is essential for DNA synthesis. Methotrexate is metabolized in the liver, and most of the drug is excreted unchanged in urine. This agent crosses the blood-brain barrier and placenta.

Cytarabine (Ara-C)

Cytarabine (Ara-C) is cell-cycle S-phase specific, blocking the progression from G1 to S phase. This agent is converted intracellularly to the active compound cytarabine-5'-triphosphate, which inhibits DNA polymerase. This inhibition, in turn, halts viral replication.

Doxorubicin (Adriamycin)

Doxorubicin is an anthracycline antibiotic that can intercalate with DNA and affects many DNA functions, including synthesis. This agent forms DNA-cleavable complexes by interacting with topoisomerase II, which is responsible for the cytocidal activity of the drug.

Doxorubicin is administered intravenously and distributes widely into body tissues, including the heart, kidneys, lungs, liver, and spleen; however, it does not cross the blood-brain barrier and is excreted primarily in bile.

Rituximab (Rituxan)

Rituximab is a genetically engineered, chimeric, murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. This antibody is an immunoglobulin (Ig) G1 kappa immunoglobulin that contains murine light- and heavy-chain variable region sequences and human constant region sequences.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!